Hypha Discovery is a microbial technology company helping partners in pharmaceutical and agrochemical R&D succeed through the discovery and production of microbial and mammalian metabolites. We are experts in the scalable production of DMPK metabolites and generation of polar analogues, and are also a leading provider of unique natural product screening libraries and associated services.
NEWS & EVENTS
Come and meet us at the following events:
February 22nd, Foster City Crowne Plaza, San Francisco, CA, US
Liam will be attending this meeting
April 6th, Hilton San Diego Bayfront, San Diego, CA, US
Liam will be presenting a poster at the conference and is looking forward to meeting you there
26th April, 2018, The Fielder Centre Hatfield, UK
Come and see us at the exhibition and at our joint poster with AstraZeneca on
“Expanding chemical space via microbial catalysed late stage functionalization”
21st-22nd May 2018, Royal Society of Chemistry at Burlington House, London, UK
Meet us at the exhibition at magnificent Burlington House in Piccadilly!
Download a copy of our brochure on drug metabolites and C-H activated derivatives
Our new brochure on drug metabolites and C-H activated derivatives is now available. Inside we feature interesting case studies and client projects, including the following topics:
- Phase l CYP and non-CYP metabolites
- Phase ll conjugated metabolites
- Isotopically labelled metabolites
- Lead diversification and late stage functionalization
- Polar / C-H activated derivatives
In our latest newsletter we look at single-step production of metabolites of drugs and agrochemicals formed from sequential oxidation and glucuronidation pathways.